These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 20307599

  • 1. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, Fu A, Cai L, Li X, Ye X, Liu Y, Wu W, Shao X, Mao Y, Wei Y, Chen L.
    J Control Release; 2010 Jul 01; 145(1):17-25. PubMed ID: 20307599
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
    Xiao W, Chen X, Yang L, Mao Y, Wei Y, Chen L.
    Int J Pharm; 2010 Jun 30; 393(1-2):119-26. PubMed ID: 20416367
    [Abstract] [Full Text] [Related]

  • 5. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
    Sochanik A, Mitrus I, Smolarczyk R, Cichoń T, Snietura M, Czaja M, Szala S.
    Arch Immunol Ther Exp (Warsz); 2010 Jun 30; 58(3):235-45. PubMed ID: 20383751
    [Abstract] [Full Text] [Related]

  • 6. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
    Garde SV, Forté AJ, Ge M, Lepekhin EA, Panchal CJ, Rabbani SA, Wu JJ.
    Anticancer Drugs; 2007 Nov 30; 18(10):1189-200. PubMed ID: 17893520
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J, Lee A, Lu Y, Lee RJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):329-35. PubMed ID: 17275230
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo.
    Al-Jamal KT, Al-Jamal WT, Wang JT, Rubio N, Buddle J, Gathercole D, Zloh M, Kostarelos K.
    ACS Nano; 2013 Mar 26; 7(3):1905-17. PubMed ID: 23527750
    [Abstract] [Full Text] [Related]

  • 12. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.
    Int J Pharm; 2009 Dec 01; 382(1-2):254-61. PubMed ID: 19666094
    [Abstract] [Full Text] [Related]

  • 13. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A.
    Clin Cancer Res; 2000 May 01; 6(5):1949-57. PubMed ID: 10815920
    [Abstract] [Full Text] [Related]

  • 14. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC.
    Clin Cancer Res; 2002 Apr 01; 8(4):1172-81. PubMed ID: 11948130
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW.
    Cancer Res; 2000 Dec 15; 60(24):6950-7. PubMed ID: 11156395
    [Abstract] [Full Text] [Related]

  • 16. Biological evaluation of a novel doxorubicin-peptide conjugate for targeted delivery to EGF receptor-overexpressing tumor cells.
    Ai S, Duan J, Liu X, Bock S, Tian Y, Huang Z.
    Mol Pharm; 2011 Apr 04; 8(2):375-86. PubMed ID: 21241067
    [Abstract] [Full Text] [Related]

  • 17. Antitumor Effects of Docetaxel in Truncated Basic Fibroblast Growth Factor- Functionalized Liposomes Delivered by d-α-tocopheryl Polyethylene Glycol 2000 Succinate.
    Wen J, Wang Z, Qiu N, Liu H, Shu X, Zhu Z, Bai P, Yang L, Chen L.
    Curr Pharm Des; 2020 Apr 04; 26(34):4338-4348. PubMed ID: 32324508
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
    Chen H, Qin Y, Zhang Q, Jiang W, Tang L, Liu J, He Q.
    Eur J Pharm Sci; 2011 Sep 18; 44(1-2):164-73. PubMed ID: 21782939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.